Q3 2014

Filed Nov 12, 2014 · 10-Q · 43 days after period end · 0001121781-14-000322

Q3 2014 · 10-Q

Revenue

$22.00K

−74.4% vs Q3 2013

Net Income

-$2.97M

N/M vs Q3 2013

EPS Diluted

-$0.04

N/M vs Q3 2013

Gross Profit$2,000N/M

Operating Income

Same quarter

Metric	Q3 2014	Q3 2013	Q3 2012	Q3 2011
Revenue	$22.00K	$86.00K	$693.00K	$1.02M
Net Income	-$2.97M	-$1.44M	-$986.00K	-$2.66M
EPS Diluted	-$0.04	-$0.02	-$0.02	-$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR